FIRST Robotics, RoboCup, BattleBots, challenges
Zebra's exit from robotics hardware paradoxically strengthens its bull case: machine vision and tracking demand is accelerating, and Zebra now sells the software layer that powers automation.
ABB's bull case is electrification and automation dominance, not robotics—which it is selling to SoftBank.
Intuitive Surgical controls 80% of robotic surgery, making surgeon lock-in its most durable competitive advantage.
Nvidia's future growth depends partly on whether robotics AI deployment scales faster than skeptics expect.
Nauticus's subsea robot partnerships prove the technology works, but mounting losses and cash depletion put execution on a razor's edge.
PROCEPT BioRobotics bypassed the crowded general-purpose surgical robot market to dominate a specific, high-volume procedure where focused engineering beats platform sprawl.
Hundreds of paying robotics customers, rising margins, and a bargain multiple — the case for Ouster as the lidar sector's overlooked value play.
The company's robots—small, wheeled vehicles designed to navigate pedestrian pathways—are expanding into major cities because they solve a specific...
Knightscope's 106% quarterly revenue growth and $40 billion addressable market mask a company burning $21.9 million in EBITDA annually with only $11.4 million in cash.
Microbot Medical trades under $1 because clinical approval remains unproven and revenue is minimal while cash burn continues relentlessly.